NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹18 Cr | ₹75 Cr | ₹38 Cr | ₹17 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹17 Cr |
| Mar2013 | ₹14 Cr |
How is Cash Flow from Operating Activities of NATH BIOGENES (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -76.43 | |
| Mar2024 | ₹75 Cr | 94.42 | |
| Mar2023 | ₹38 Cr | 125.05 | |
| Mar2022 | ₹17 Cr | 19.96 | |
| Mar2013 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹270.9 Cr | 1.5% | -4.6% | -6.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,634.6 Cr | -0.8% | -17.7% | -12.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,168.6 Cr | 5.6% | -9.3% | -24.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,709.7 Cr | -4.1% | -15.9% | -24.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹861.0 Cr | -1.6% | -10.7% | -38.2% | Stock Analytics | |
| INDO US BIOTECH | ₹198.8 Cr | -3.1% | -24.8% | -46.6% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 1.5% |
-4.6% |
-6.5% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses